Article Details
Retrieved on: 2025-02-28 21:11:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Roche. 1. The off-the-shelf glofitamab-based combination may become the first commercially available bispecific antibody regimen for this DLBCL ...
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here